Cholecystokinin-1 receptor antagonists:5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents

Lattmann, E., Russell, S.T., Schwalbe, C.H., Shortt, A., Balaram, P.N., Theochari, E., Alharbi, M., Narayanan, R. and Lattmann, P. (2016). Cholecystokinin-1 receptor antagonists:5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. MedChemComm, 7 (6), pp. 1138-1145.

Abstract

A new class of 5-arylated 5-hydroxypyrrolones was derived from mucochloric acid in 2 synthetic steps and the chemical structure was confirmed additionally by X-ray analysis. Using a radiolabelled binding assay, potent CCK1 selective ligands were identified (CCK1: 12 nM) and the antagonism was confirmed by using isolated tissue preparations. A series of isobutyl derivatives displayed unsurmountable CCK antagonistic properties and in vitro excellent inhibition of proliferation was obtained in cholecystokinin related cancer cell lines in the nanomolar range. Finally, using xenograft studies in nude mice, two selected pyrrolone derivatives, X = H and X = F a fluorinated analogue (PNB-028), showed a strong inhibition of tumour growth in a chemo-resistant colon cancer-(MAC 16) and a human pancreatic cell line (MIAPACA) at 50 mg kg-1 by oral administration.

Publication DOI: https://doi.org/10.1039/c6md00052e
Divisions: Life & Health Sciences > Pharmacy
Life & Health Sciences
Life & Health Sciences > Cell & Tissue Biomedical Research
Life & Health Sciences > Biosciences
Uncontrolled Keywords: Biochemistry,Pharmaceutical Science
Full Text Link: http://pubs.rsc ... 2E#!divAbstract
Related URLs: http://www.scop ... tnerID=8YFLogxK (Scopus URL)
Published Date: 2016-06-01
Authors: Lattmann, E.
Russell, S.T.
Schwalbe, C.H.
Shortt, A.
Balaram, P.N.
Theochari, E.
Alharbi, M.
Narayanan, R.
Lattmann, P.

Download

[img]

Version: Accepted Version

| Preview

Export / Share Citation


Statistics

Additional statistics for this record